471 related articles for article (PubMed ID: 31666238)
21. Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice.
Yamazaki C; Miyamoto R; Hoshino K; Fukuda Y; Sasaki I; Saito M; Ishiguchi H; Yano T; Sugiyama T; Hemmi H; Tanaka T; Hamada E; Hirashima T; Amakawa R; Fukuhara S; Nomura S; Ito T; Kaisho T
Biochem Biophys Res Commun; 2010 Jul; 397(4):756-61. PubMed ID: 20541533
[TBL] [Abstract][Full Text] [Related]
22. STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC.
Han Q; Wang Y; Pang M; Zhang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):156. PubMed ID: 29115974
[TBL] [Abstract][Full Text] [Related]
23. A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC.
Du K; Li Y; Liu J; Chen W; Wei Z; Luo Y; Liu H; Qi Y; Wang F; Sui J
Mol Ther; 2021 Apr; 29(4):1572-1584. PubMed ID: 33429083
[TBL] [Abstract][Full Text] [Related]
24. [Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma].
Nishimura Y; Nakatsura T; Senju S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):383-91. PubMed ID: 18974622
[TBL] [Abstract][Full Text] [Related]
25. [Cancer peptide vaccine targeted glypican-3 antigen].
Nakatsura T
Nihon Rinsho; 2017 Feb; 75(2):257-262. PubMed ID: 30562861
[TBL] [Abstract][Full Text] [Related]
26. Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells.
Wang Y; Wang Y; Mu H; Liu T; Chen X; Shen Z
Mol Med Rep; 2015 May; 11(5):3361-7. PubMed ID: 25625609
[TBL] [Abstract][Full Text] [Related]
27. GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy.
Lu LL; Xiao SX; Lin ZY; Bai JJ; Li W; Song ZQ; Zhou YH; Lu B; Wu WZ
Cell Biol Toxicol; 2023 Dec; 39(6):3101-3119. PubMed ID: 37853185
[TBL] [Abstract][Full Text] [Related]
28. Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control.
Botelho NK; Tschumi BO; Hubbell JA; Swartz MA; Donda A; Romero P
Front Immunol; 2019; 10():294. PubMed ID: 30863405
[TBL] [Abstract][Full Text] [Related]
29. PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma.
Wang P; Qin W; Liu T; Jiang D; Cui L; Liu X; Fang Y; Tang X; Jin H; Qian Q
Immunobiology; 2020 Jan; 225(1):151850. PubMed ID: 31522780
[TBL] [Abstract][Full Text] [Related]
30. Anticancer effects of chemokine-directed antigen delivery to a cross-presenting dendritic cell subset with immune checkpoint blockade.
Mizumoto Y; Hemmi H; Katsuda M; Miyazawa M; Kitahata Y; Miyamoto A; Nakamori M; Ojima T; Matsuda K; Nakamura M; Hayata K; Fukuda-Ohta Y; Sugiyama M; Ohta T; Orimo T; Okura S; Sasaki I; Tamada K; Yamaue H; Kaisho T
Br J Cancer; 2020 Apr; 122(8):1185-1193. PubMed ID: 32066911
[TBL] [Abstract][Full Text] [Related]
31. A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine.
Shi W; Yang X; Xie S; Zhong D; Lin X; Ding Z; Duan S; Mo F; Liu A; Yin S; Jiang X; Xu ZPG; Lu X
Cancer Lett; 2021 Dec; 522():184-197. PubMed ID: 34562519
[TBL] [Abstract][Full Text] [Related]
32. The invariant natural killer T cell-mediated chemokine X-C motif chemokine ligand 1-X-C motif chemokine receptor 1 axis promotes allergic airway hyperresponsiveness by recruiting CD103
Woo YD; Koh J; Kang HR; Kim HY; Chung DH
J Allergy Clin Immunol; 2018 Dec; 142(6):1781-1792.e12. PubMed ID: 29474842
[TBL] [Abstract][Full Text] [Related]
33. Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate.
Waaijer SJ; Giesen D; Ishiguro T; Sano Y; Sugaya N; Schröder CP; de Vries EG; Lub-de Hooge MN
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217763
[TBL] [Abstract][Full Text] [Related]
34. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256
[TBL] [Abstract][Full Text] [Related]
35. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
36. [Construction and function of Glypican-3-targeted fourth-generation chimeric antigen receptor T cells (secreting IL-7 and CCL19)].
Huang W; Liu Y; Hu Y; Gao J
Sheng Wu Gong Cheng Xue Bao; 2020 May; 36(5):979-991. PubMed ID: 32567281
[TBL] [Abstract][Full Text] [Related]
37. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.
Fossum E; Grødeland G; Terhorst D; Tveita AA; Vikse E; Mjaaland S; Henri S; Malissen B; Bogen B
Eur J Immunol; 2015 Feb; 45(2):624-35. PubMed ID: 25410055
[TBL] [Abstract][Full Text] [Related]
38. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells.
Crozat K; Guiton R; Contreras V; Feuillet V; Dutertre CA; Ventre E; Vu Manh TP; Baranek T; Storset AK; Marvel J; Boudinot P; Hosmalin A; Schwartz-Cornil I; Dalod M
J Exp Med; 2010 Jun; 207(6):1283-92. PubMed ID: 20479118
[TBL] [Abstract][Full Text] [Related]
39. Peptide vaccine as an adjuvant therapy for glypican-3-positive hepatocellular carcinoma induces peptide-specific CTLs and improves long prognosis.
Taniguchi M; Mizuno S; Yoshikawa T; Fujinami N; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Nakatsura T
Cancer Sci; 2020 Aug; 111(8):2747-2759. PubMed ID: 32449239
[TBL] [Abstract][Full Text] [Related]
40. Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.
Dorner BG; Dorner MB; Zhou X; Opitz C; Mora A; Güttler S; Hutloff A; Mages HW; Ranke K; Schaefer M; Jack RS; Henn V; Kroczek RA
Immunity; 2009 Nov; 31(5):823-33. PubMed ID: 19913446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
